Immunonutrition before and during radiochemotherapy: Improvement of inflammatory parameters in head and neck cancer patients

Supportive Care in Cancer

Volumn 20, Issue 12, 2012, Pages 3129-3135

  MacHon, Christelle ^a   Thezenas, Simon ^b   Dupuy, Anne Marie ^a   Assenat, Eric ^b   Michel, Françoise ^a   Mas, Emilie ^a   Senesse, Pierre ^b   Cristol, Jean Paul ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b CENTRE VAL D AURELLE   (France)

Author keywords

Head and neck cancer; Immunonutrition; Inflammation; Radiochemotherapyinduced toxicities

Indexed keywords

AMINO ACID; ARGININE; C REACTIVE PROTEIN; CISPLATIN; CREATININE; GLUTAMINE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROSTANE DERIVATIVE; OMEGA 3 FATTY ACID; OROSOMUCOID; PROCALCITONIN; RNA; TRACE ELEMENT; VASCULOTROPIN; VITAMIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNOMODULATION; IMMUNONUTRITION; INFLAMMATION; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ACUTE-PHASE PROTEINS; ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CYTOKINES; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INFLAMMATION; ISOPROSTANES; MALE; MIDDLE AGED; MUCOSITIS; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PILOT PROJECTS; PROSPECTIVE STUDIES; RNA; VITAMINS;

EID: 84868507598     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1444-5     Document Type: Article

References (43)

1. Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695-1709
2. IARC (2008) World cancer report 2008. International Agency for Research on Cancer, Lyonn
3. Pivot X, Felip E, On behalf of the ESMO Guidelines Working Group (2008) Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19(Suppl 2):ii79-ii80
4. Cooper JS, Pajak TF, Forastiere AA, for the Radiation Therapy Oncology Group 9501/Intergroup et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937-1944
5. Bernier J, Domenge C, Ozsahin M, for the European Organization for Research and Treatment of Cancer Trial 22931 et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945-1952
6. Trotti A, Byhardt R, Stetz J, for the Radiation Therapy Oncology Group et al (2000) Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47(1):13-47
7. Trotti A (2000) Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 47(1):1-12
8. Langendijk JA, de Jong MA, Leemans CR et al (2002) Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time. Int J Radiat Oncol Biol Phys 54:229-236
9. Assenat E, Thezenas S, Flori N et al (2011) Prophylactic percutaneous endoscopic gastrostomy in patients with advanced head and neck tumors treated by combined chemoradiotherapy. J Pain Symptom Manage 42(4):548-556
10. Braga M, Gianotti L, Radaelli G et al (1999) Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 134:428-433
11. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V (2002) A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 122:1763-1770
12. Stableforth WD, Thomas S, Lewis SJ (2009) A systematic review of the role of immunonutrition in patients undergoing surgery for head and neck cancer. Int J Oral Maxillofac Surg 38:103-110
13. Paccagnella A, Morello M, Da Mosto MC et al (2010) Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer 18:837-845
14. Kemen M, Senkal M, Homann HH et al (1995) Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med 23(4):652-659
15. Weimann A, Bastian L, Bischoff et al (1998) Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma. Nutrition 14(2):165-172
16. Sorensen D, McCarthy M, Baumgartner B, Demars S (2009) Perioperative immunonutrition in head and neck cancer. Laryngoscope 119:1358-1364
17. Portales F, Assenat E, Latournerie M et al (2008) Phase II clinical trial assessing the impact of an oral immunonutrition during concomitant chemoradiotherapy in advanced local-regional squamous cell carcinomas of the head and neck. J Clin Oncol 26(20 supp; abstract:9629))
18. Haute Autorité de Santé (2007) Recommandations professionnelles. Stratégie de prise en charge en cas de dénutrition protéino- énergétique chez la personne âgée. Avril 2007. http://www.has-sante.fr/portail/jcms/c-546549/. Accessed 22 June 2011
19. Buzby GP, Knox LS, Crosby LO et al (1988) Study protocol: a randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Am J Clin Nutr 47:366-381
20. Badiou S, Cristol JP, Jaussent I et al (2008) Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determination. Clin J Am Soc Nephrol 3(2):423-430
21. Dupuy AM, Lehmann S, Cristol JP (2005) Protein biochip systems for the clinical laboratory. Clin Chem Lab Med 43(12):1291-1302
22. Mas E, Michel F, Guy A et al (2008) Quantification of urinary F2- isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry: application to polytraumatized patients. J Chrom B 872:133-140
23. Monnier L, Mas E, Ginet C et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681-1687
24. Wang F, Arun P, Friedman J, Chen Z, Van Waes C (2009) Current and potential inflammation targeted therapies in head and neck cancer. Curr Opin Pharmacol 9(4):389-395
25. Woods RV, El-Naggar A, Clayman GL, Grimm E (1998) Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res 58(14):3132-3141
26. Chen Z, Malhotra PS, Thomas GR et al (1999) Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5:1369-1379
27. Allin KH, Bojesen SE, Nordestgaard BG (2009) Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27(13):2217-2224
28. Shang ZJ, Li JR, Li ZB (2002) Circulating levels of VEGF in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg 31:495-498
29. Prawan A, Buranrat B, Kukongviriyapan U, Sripa B, Kukongviriyapan V (2009) Inflammatory cytokines suppress NAD(P)H:quinone oxidoreductase-1 and induce oxidative stress in cholangiocarcinoma cells. J Cancer Res Clin Oncol 135(4):515-522
30. Rasheed MH, Beevi SS, Geetha A (2007) Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma. Oral Oncol 43:333-338
31. Nagini S, Manoharan S, Ramachandran CR (1998) Lipid peroxidation and antioxidants in oral squamous cell carcinoma. Clin Chim Acta 273:95-98
32. LiuW,Morrow JD, Yin H (2009) Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography- mass spectrometry (GC-MS) method. Free Radic Biol Med 47:1101-1107
33. Dalaveris E, Kerenidi T, Katsabeki-Katsafli A et al (2009) VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer 64(2):219-225
34. Rossner P, Gammon MD, Terry MB et al (2006) Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15(4):639-644
35. Cengiz M, Akbulut S, Atahan IL, Grigsby PW (2001) Acute phase response during radiotherapy. Int Radiat Oncol Biol Phys 49 (4):1093-1096
36. Ki Y, Kim W, Nam J, Kim D, Park D, Kim D (2009) C-reactive protein levels and radiation-induced mucositis in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 75(2):393-398
37. De Luis DA, Arranz M, Aller R, Izaola O, Cuellar L, Terroba MC (2005) Immunoenhanced enteral nutrition, effect on inflammatory markers in head and neck cancer patients. EJCN 59:145-147
38. De Luis DA, Aller R, Izaola O, Cuellar L, Terroba MC (2002) Postsurgery enteral nutrition in head and neck cancer patients. EJCN 56:1126-1129
39. Riso S, Aluffi P, Brugnani M, Farinetti F, Pia F, D'Andrea F (2000) Postoperative enteral immunonutrition in head and neck cancer patients. Clin Nutr 19(6):407-412
40. Snyderman CH, Kachman K, Molseed L et al (1999) Reduced postoperative infections with an immune-enhancing nutritional supplement. Laryngoscope 109(6):915-921
41. Caparrós T, Lopez J, Grau T (2001) Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet. The effect on nosocomial infections and outcome. J Parenter Enter Nut 25(6):299-308
42. Bensadoun RJ, Le Page F, Darcourt V et al (2006) Mucite radioinduite des voies aérodigestives: prévention et prise en charge. Recommandations du groupe Mucites MASCC/ISOO. Bull Cancer 93(2):201-211
43. Meirovitz A, Kuten M, Billan S et al (2010) Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer - a prospective pilot study. Radiat Oncol 5:16